Home » Stocks » Evoke Pharma

Evoke Pharma, Inc. (EVOK)

Stock Price: $5.36 USD -0.01 (-0.20%)
Updated Aug 12, 2020 1:40 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 139.39M
Revenue (ttm) n/a
Net Income (ttm) -11.80M
Shares Out 24.70M
EPS (ttm) -0.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $5.36
Previous Close $5.37
Change ($) -0.01
Change (%) -0.20%
Day's Open 5.40
Day's Range 5.33 - 5.69
Day's Volume 759,049
52-Week Range 0.73 - 6.06

More Stats

Market Cap 139.39M
Enterprise Value 133.58M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 24.70M
Float 21.89M
EPS (basic) -0.48
EPS (diluted) -0.48
FCF / Share -0.21
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.22M
Short Ratio 0.26
Short % of Float 3.70%
Beta 2.03
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 34.67
Revenue n/a
Operating Income -11.82M
Net Income -11.80M
Free Cash Flow -5.31M
Net Cash 5.82M
Net Cash / Share 0.22
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -92.93%
ROE -395.28%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.00*
Low
10.0
Current: $5.36
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue---------
Operating Income-7.15-8.01-11.23-10.54-11.82-13.25-2.60-2.00-2.41
Net Income-7.13-7.57-12.23-10.75-12.12-13.25-2.84-2.02-2.40
Shares Outstanding22.3016.6014.909.346.496.032.371.121.10
Earnings Per Share-0.32-0.46-0.90-1.15-1.87-2.20-1.20-1.79-2.18
Operating Cash Flow-5.76-6.98-8.72-8.71-10.50-11.50-3.04-1.75-2.89
Free Cash Flow-5.76-6.98-8.72-8.71-10.50-11.50-3.04-1.75-2.89
Cash & Equivalents5.665.327.689.018.6914.1624.200.120.87
Total Debt0.14---4.384.322.950.98-
Net Cash / Debt5.535.327.689.014.319.8321.24-0.860.87
Assets6.405.667.949.299.5315.2324.990.120.91
Liabilities2.021.635.785.516.076.043.801.550.33
Book Value4.384.032.173.793.469.1921.18-19.66-17.65
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Evoke Pharma, Inc.
Country United States
Employees 5
CEO David A. Gonyer

Stock Information

Ticker Symbol EVOK
Stock Exchange NASDAQ
Sector Healthcare
Industry Drugs - Generic
Unique Identifier NASDAQ: EVOK
IPO Date September 25, 2013

Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which is completed Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California.